HealthcareServices

Revenue of the Constipation Treatment Market Predicted to Achieve $18.71 Billion by 2030, Driven by 8% CAGR

February 23, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the constipation treatment market from 2026–2035 with trusted insights from The Business Research Company

What upper market value could the Constipation Treatment Market reach by 2030 starting from 2026 levels?

The constipation treatment market size has shown significant expansion in recent years. It is anticipated to increase from $12.71 billion in 2025 to $13.75 billion in 2026, registering a compound annual growth rate (CAGR) of 8.2%. The factors contributing to this growth historically include the high prevalence of gastrointestinal disorders, sedentary lifestyle patterns, dietary fiber deficiency, reliance on traditional laxatives, and aging population growth.

The constipation treatment market is projected to experience robust expansion over the coming years, set to reach a value of $18.72 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.0%. This anticipated growth during the forecast period is fueled by several factors, including an increase in chronic constipation diagnoses, greater use of opioids, heightened public understanding of gut health, the spread of specialized gastroenterology services, and enhanced availability of new therapeutic options. Key trends anticipated within the same period encompass a surge in the utilization of prescribed treatments for chronic constipation, a rise in the uptake of probiotics and other gut health items, a move towards pharmaceuticals with specific mechanisms of action, an intensified emphasis on managing constipation resulting from opioid use, and the wider distribution through online pharmacies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12134&type=smp

Which Drivers Are Influencing Long-Term Growth In The Constipation Treatment Market?

The increasing incidence of gastrointestinal disorders is anticipated to boost the growth of the constipation treatment market moving forward. Gastrointestinal disorders, frequently referred to as digestive disorders, encompass a variety of conditions impacting the digestive tract. Constipation is a common symptom associated with many gastrointestinal (GI) conditions. The rising prevalence of gastrointestinal disorders, including irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), fuels the expansion of the constipation treatment market as these ailments often occur alongside constipation, thereby fostering a greater need for specific and effective treatments amid heightened awareness. For instance, in January 2024, the American Cancer Society, a US-based non-profit organization, projected approximately 26,890 new cases of stomach cancer in the U.S. in 2024, with 16,160 cases in men and 10,730 in women. It is also expected that this cancer type will result in about 10,880 deaths, comprising 6,490 men and 4,390 women. Therefore, the growing occurrence of gastrointestinal disorders is driving the growth of the constipation treatment market.

How Is The Constipation Treatment Market Divided Into Segments?

The constipation treatment market covered in this report is segmented –

1) By Therapeutic Types: Laxatives, Chloride Channel Activators, Peripherally Acting Mu-Opioid Receptor Antagonists, Guanylate Cyclase-C (GC-C) Agonists, Other Therapeutics

2) By Disease Type: Chronic Idiopathic Constipation (CIC), Irritable Bowel Syndrome With Constipation (IBS-C), Opioid-Induced Constipation (OIC)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Laxatives: Bulk-Forming Laxatives, Osmotic Laxatives, Stimulant Laxatives, Stool Softeners

2) By Chloride Channel Activators: Lubiprostone-Based Formulations, Other Chloride Channel Activators

3) By Peripherally Acting Mu-Opioid Receptor Antagonists: Methylnaltrexone Formulations, Naloxegol Formulations, Other PAMORAs

4) By Guanylate Cyclase-C (GC-C) Agonists: Linaclotide Formulations, Plecanatide Formulations, Other GC-C Agonists

5) By Other Therapeutics: Prokinetic Agents, Serotonin 5-HT4 Receptor Agonists, Herbal and Alternative Formulations

How Are New Market Trends Shaping The Landscape Of The Constipation Treatment Market?

Major companies operating in the constipation treatment market are actively engaged in the creation of innovative solutions, including drug-free mechanical stimulation capsules (vibrating capsules). This endeavor aims to satisfy the increasing demand for efficacious therapies with minimal side effects, a need propelled by an aging population, greater opioid usage, and patient inclination towards non-pharmacologic options. A vibrating capsule is an ingestible, single-use oral device that encloses a small vibration motor and battery within a medical-grade, excretable shell; it is engineered to mechanically stimulate the colon at programmed intervals to induce peristalsis, thereby providing predictable bowel movements without the systemic effects typical of laxatives or prescription prokinetics. For instance, in May 2023, Vibrant Ltd., a US-based medical technology company, launched Vibrant, a prescription-only vibrating capsule system approved by the U.S. Food and Drug Administration (FDA) for adults suffering from chronic idiopathic constipation who have not found relief with laxatives. The system includes a reusable activation pod and a single-use capsule containing a coin-sized vibration motor, an electronic control card, and batteries, all encased in a two-piece shell. The pod configures the capsule, which subsequently delivers a series of short vibration cycles, approximately 190 cycles per hour with timed bursts and rests, all designed to stimulate colonic contractions.

Which Leading Companies Dominate The Constipation Treatment Market Share?

Major companies operating in the constipation treatment market are Pfizer, Johnson & Johnson, AbbVie, Bayer, Sanofi, Fresenius Kabi, GlaxoSmithKline, Takeda Pharmaceutical Company Ltd, Bausch Health Companies Inc, Salix Pharmaceuticals Inc, Prestige Consumer Healthcare Inc, Ironwood Pharmaceuticals Inc, Cosmo Pharmaceuticals NV, Ferring Pharmaceuticals, Probi AB, 4D Pharma plc, Abbott Laboratories, Albireo Pharma Inc, Ardelyx Inc, Synergy Pharmaceuticals Inc, Astellas Pharma Inc, Allergan plc

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Constipation Treatment Market?

North America was the largest region in the constipation treatment market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the constipation treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Constipation Treatment Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12134&type=smp

Browse Through More Reports Similar to the Global Constipation Treatment Market 2026, By The Business Research Company

Inflammatory Bowel Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Constipation Laxative Market Report 2026

https://www.thebusinessresearchcompany.com/report/constipation-laxative-global-market-report

Opioid Induced Constipation Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/opioid-induced-constipation-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795